Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$73,435,228
+$25,508,964 QoQ
Shares Held
5,728,177
+7.4% QoQ
Ownership
4.10%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Dec 31, 2025CallValue
$747,069
CallShares
83,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. NTLA ranks #14 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $73,435,228 | 5,728,177 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $747,069 | 83,100 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $47,926,264 | 5,331,064 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $38,484,468 | 2,228,400 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,735,939 | 824,727 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $249,561 | 35,100 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $230,335 | 32,396 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $391,577 | 33,583 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $752,070 | 64,500 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $963,795 | 46,900 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $252,354 | 12,280 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $671,400 | 30,000 | Put | Defined | 2024-08-14 | |
| 2022-12-31 | $528,653 | 15,152 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,885,913 | 51,571 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,067,876 | 426,350 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $15,871,782 | 218,409 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $311,444 | 2,634 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,012,250 | 15,000 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $1,345,792 | 10,032 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,618,354 | 114,992 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $2,428,650 | 15,000 | Put | Defined | 2021-08-16 | |
| 2021-03-31 | $32,400,548 | 403,720 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $19,658,582 | 361,371 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,418,743 | 171,969 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,087,570 | 194,461 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||